Abstract:Targeting delivery of photosensitizers to mitochondria as the most sensitive cellular organelles to reactive oxygen species (ROS) by positively charged polymeric nanocarriers (NCs) is one of the useful methods for efficient photodynamic therapy (PDT). However, the NCs with positively charged mitochondria-targeting moieties are easily cleaned during circulation, restricting their in vivo applications. Herein, to address this issue and enhance in vivo PDT efficacy, we developed a sequential-targeting delivery system consisting of mitochondria-targeting micelles as the core prepared from the cationic amphiphilic copolymer for loading chlorin e6 (Ce6) and a tumor-targeting pH-dependent charge transformational layer as the shell obtained from 2,3-dimethylmaleic anhydride modified Biotin-PEG(4000)-NH2 (BioPEGDMA) via electrostatic interaction. Concealed by the anionic shell, the as-prepared NCs showed longer retention within the first stage of tumor-targeting. Then, the accumulated NCs conversed to positive charge in tumor extracellular microenvironment (pH similar to 6.5), which could be more effectively internalized by tumor cells, and the re-exposed triphenylphosphonium (TPP) groups endowed their second-stage targetability to the mitochondria. In vivo experiments revealed that the Ce6-loaded NCs exhibited remarkable tumor inhibition rates of 84.1% and 93.2% on BALI* nude mice and Kunming mice, respectively, under 660 nm NIR irradiation, and stimulated immune responses with upregulated expression of IFN-gamma, TNF-alpha and CD3(+) in tumor tissues, and enhanced activation of CD3(+)/CD4(+), CD3(+)/CD8(+) T lymphocytes and DCs in both tumor tissues and lymph glands. This work provided a new pathway for the development of smart drug delivery system with advanced PDT efficacy. Statement of significance Although the existing targeting delivery of photosensitizers to mitochondria by positively charged nanocarriers (NCs) have efficiently enhanced photodynamic therapy (PDT), their positive charges caused rapid clearance during circulation, which has restricted their in vivo applications. Therefore, we fabricated a novel sequential-targeting NC to solve the problem. The tumor accumulated NCs conversed to positive charge in tumor extracellular microenvironment, and the re-exposed triphenylphosphonium groups initiated second-stage targetability to mitochondria. This system exhibited remarkable tumor inhibition efficiency both in vitro and in vivo. Moreover, as we hypothesized, mitochondria-located PDT could promote immune response, resulting in improvement of PDT. The strategy of sequential targeting-based PDT in combination with augmented immune response showed a novel pathway for the development of smart drug delivery system with advanced PDT. (C) 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Novel Mitochondrial Targeting Multifunctional Surface Charge-Reversal Polymeric Nanoparticles for Cancer Treatment

Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery

In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle

Mitochondrial Targeting Nanodrugs Self-Assembled from 9-O-octadecyl Substituted Berberine Derivative for Cancer Treatment by Inducing Mitochondrial Apoptosis Pathways.

Hierarchical Targeted Hepatocyte Mitochondrial Multifunctional Chitosan Nanoparticles for Anticancer Drug Delivery.

Charge-Reversible Multifunctional HPMA Copolymers for Mitochondrial Targeting.

Stepwise Dual Targeting and Dual Responsive Polymer Micelles for Mitochondrion Therapy.

Ph-Sensitive Small Molecule Nanodrug Self-Assembled from Amphiphilic Vitamin B6-E Analogue Conjugate for Targeted Synergistic Cancer Therapy

Development of a novel berberine-mediated mitochondria-targeting nano-platform for drug-resistant cancer therapy

Mitochondria-targeting polydopamine-coated nanodrugs for effective photothermal- and chemo-synergistic therapies against lung cancer

Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer

Preparation, in Vitro and in Vivo Evaluation of Polymeric Nanoparticles Based on Hyaluronic Acid-Poly(butyl Cyanoacrylate) and D-alpha-tocopheryl Polyethylene Glycol 1000 Succinate for Tumor-Targeted Delivery of Morin Hydrate.

A Tumor-Mitochondria Dual Targeted Aza-Bodipy-based Nanotheranostic Agent for Multimodal Imaging-Guided Phototherapy

Mitochondrion-Directed Nanoparticles Loaded with a Natural Compound and a microRNA for Promoting Cancer Cell Death via the Modulation of Tumor Metabolism and Mitochondrial Dynamics

Mitochondria-targeting Nanomedicine Self-Assembled from GSH-responsive Paclitaxel-Ss-berberine Conjugate for Synergetic Cancer Treatment with Enhanced Cytotoxicity.

Dual pH-responsive and CD44 receptor targeted multifunctional nanoparticles for anticancer intracellular delivery

Endosomal pH, Redox Dual-Sensitive Prodrug Micelles Based on Hyaluronic Acid for Intracellular Camptothecin Delivery and Active Tumor Targeting in Cancer Therapy

Multi-responsive Nanococktails with Programmable Targeting Capacity for Imaging-Guided Mitochondrial Phototherapy Combined with Chemotherapy.

Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy.

Ph-Sensitive Polymeric Nanoparticles for Co-Delivery of Doxorubicin and Curcumin to Treat Cancer Via Enhanced Pro-Apoptotic and Anti-Angiogenic Activities

Self-Assembled Nanomedicine Combining A Berberine Derivative And Doxorubicin For Enhanced Antitumor And Antimetastatic Efficacy Via Mitochondrial Pathways Dagger